[
    [
        {
            "time": "",
            "original_text": "【泰格医药|一季报点评】短期疫情不改长期向好趋势，临床CRO龙头前景可期【安信医药】",
            "features": {
                "keywords": [
                    "泰格医药",
                    "一季报",
                    "疫情",
                    "长期向好",
                    "临床CRO",
                    "龙头"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "临床CRO"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【泰格医药|一季报点评】短期疫情不改长期向好趋势，临床CRO龙头前景可期【安信医药】",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "两股连续十日获外资增持 | 粤开策略资金面日报-0429",
            "features": {
                "keywords": [
                    "外资增持",
                    "连续十日",
                    "粤开策略",
                    "资金面"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "两股连续十日获外资增持 | 粤开策略资金面日报-0429",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 4,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "【国元医药】泰格医药2020一季报点评：疫情影响逐渐消散，行业有望恢复增长",
            "features": {
                "keywords": [
                    "国元医药",
                    "泰格医药",
                    "2020一季报",
                    "疫情影响",
                    "消散",
                    "行业恢复增长"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【国元医药】泰格医药2020一季报点评：疫情影响逐渐消散，行业有望恢复增长",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        }
    ]
]